Therefore, we have used exome and genome sequencing data (1) to identify rare and low-frequency coding variants in BIN1, CLU, CR1, PICALM, MS4A6A, ABCA7, EPHA1, CD33, and CD2AP and (2) to investigate their single independent and combined effect on AD susceptibility. Here, CD2AP is linked to Alzheimer disease.